Open access · US-GOV
via ClinicalTrials.gov Clinical trial
VITAL-Age Trial (iVS-1 Investigation for Targeting Aging and Longevity)
Authors not listed
Synbiotic Health · 2026
Abstract
This study is a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effects of Bifidobacterium adolescentis (iVS-1) supplementation on biological aging markers, metabolic health, and functional health outcomes in midlife adults. The study explores whether modulation of aging-related biological pathways through the gut microbiome may influence health-related outcomes.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-07-02 MST
Cite this
APA
Anonymous. (2026). VITAL-Age Trial (iVS-1 Investigation for Targeting Aging and Longevity). <em>Synbiotic Health</em>. https://clinicaltrials.gov/study/NCT07407894
Vancouver
Anonymous. VITAL-Age Trial (iVS-1 Investigation for Targeting Aging and Longevity). Synbiotic Health. 2026.
BibTeX
@misc{anon2026VITALA,
title = {VITAL-Age Trial (iVS-1 Investigation for Targeting Aging and Longevity)},
author = {Anonymous},
journal = {Synbiotic Health},
year = {2026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.